Railroading at the FDA

Nat Biotechnol. 2016 Nov 8;34(11):1078. doi: 10.1038/nbt.3733.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Trials as Topic
  • Decision Making
  • Drug Approval
  • Humans
  • Morpholinos / therapeutic use
  • Muscular Dystrophy, Duchenne / drug therapy
  • United States
  • United States Food and Drug Administration*

Substances

  • Morpholinos
  • eteplirsen